Ovarian cancer in elderly women

被引：1

作者：

Conte, PF

Romanini, A

Brunetti, I

Giannessi, P

Fanucchi, A

Gadducci, A

机构：

[1] ST CHIARA HOSP,DIV GYNECOL,PISA,ITALY

[2] UNIV PISA,I-56100 PISA,ITALY

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 1997年 / 7卷

关键词：

carboplatin; elderly patients; ovarian cancer; paclitaxel;

D O I：

10.1046/j.1525-1438.7.s1.2.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The incidence of ovarian cancer is > 50% in women aged greater than or equal to 65 years. Histology and stage at diagnosis are both related to age, which appears to be an independent prognostic factor for survival in univariate analysis. Special conditions relating to the treatment of elderly women with ovarian cancer and the drugs active in this disease are discussed. New, less toxic combinations of paclitaxel (Taxol(R), Bristol-Myers Squibb Company) and platinum-derived compounds appear to be promising.

引用

页码：23 / 26

页数：4

共 39 条

[1]

ALBERTS DS, 1993, CANCER-AM CANCER SOC, V71, P618

[2]

ARBUCK SG, 1993, MONOGR NCI, V15, P117

[3]

Balducci L, 1992, Oncology (Williston Park), V6, P62

[4]

BALDUCCI L, 1989, SEMIN ONCOL, V16, P76

[5]

BARKOWSKI JM, 1994, CANC CHEMOTHER PHARM, V33, P493

[6]

BECOUARN Y, 1992, CANCER CHEMOTHER PHA, V29, P159

[7]

BEGG CB, 1989, CANCER ELDERLY APPRO, P149

[8]

BICHER A, 1993, CANCER, V71, P594

[9]

CALVERT AH, 1995, SEMIN ONCOL, V22, P91

[10] CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].

CALVERT, AH ;

NEWELL, DR ;

GUMBRELL, LA ;

OREILLY, S ;

BURNELL, M ;

BOXALL, FE ;

SIDDIK, ZH ;

JUDSON, IR ;

GORE, ME ;

WILTSHAW, E .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756

← 1 2 3 4 →